These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8632608)

  • 21. Role of chromosome 9 in human bladder cancer.
    Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
    Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA polymerase beta gene mutations in human bladder cancer.
    Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
    Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelotype analysis of esophageal squamous cell carcinoma.
    Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
    Hirao S; Hirao T; Marsit CJ; Hirao Y; Schned A; Devi-Ashok T; Nelson HH; Andrew A; Karagas MR; Kelsey KT
    Cancer; 2005 Nov; 104(9):1918-23. PubMed ID: 16149093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G; Presti JC; Reuter VE; Zhang ZF; Sarkis AS; Fair WR; Cordon-Cardo C
    Diagn Mol Pathol; 1993 Mar; 2(1):4-13. PubMed ID: 7904525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.
    Kim MS; Li SL; Bertolami CN; Cherrick HM; Park NH
    Anticancer Res; 1993; 13(5A):1405-13. PubMed ID: 8239512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
    Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
    Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor-suppressor genes].
    Horikawa I; Oshimura M
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):153-9. PubMed ID: 1671547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
    Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
    Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The multiple tumor suppressor genes in human esophageal cancer].
    Li HC; Lu SX
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):489-91, 519. PubMed ID: 7994660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors.
    Vladusić T; Hrasćan R; Vrhovac I; Kruslin B; Gamulin M; Grgić M; Pećina-Slaus N; Franekić Colić J
    Pathol Res Pract; 2010 Mar; 206(3):163-7. PubMed ID: 20092957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
    Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
    Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci.
    Miyamoto H; Kubota Y; Shuin T; Shiozaki H
    Cancer Genet Cytogenet; 1996 Jun; 88(2):181-3. PubMed ID: 8640732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.